Based on hierarchical classification and logistic regression of early US and French COVID-19 clinical trials we show that despite the registration of a large number of trials, only a minority had characteristics usually associated with providing robust and relevant evidence.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1017/jme.2021.19 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!